Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Allergy
Published in: Clinical and Translational Allergy 1/2018

Open Access 01-12-2018 | Review

Highlights and recent developments in airway diseases in EAACI journals (2017)

Authors: J. Bousquet, C. A. Akdis, C. Grattan, P. A. Eigenmann, K. Hoffmann-Sommergruber, P. W. Hellings, I. Agache

Published in: Clinical and Translational Allergy | Issue 1/2018

Login to get access

Abstract

The European Academy of Allergy and Clinical Immunology (EAACI) owns three journals: Allergy, Pediatric Allergy and Immunology and Clinical and Translational Allergy. One of the major goals of EAACI is to support health promotion in which prevention of allergy and asthma plays a critical role and to disseminate the knowledge of allergy to all stakeholders including the EAACI junior members. There was substantial progress in 2017 in the identification of basic mechanisms of allergic and respiratory disease and the translation of these mechanisms into clinics. Better understanding of molecular and cellular mechanisms, efforts for the development of biomarkers for disease prediction, novel prevention and intervention studies, elucidation of mechanisms of multimorbidies, entrance of new drugs in the clinics as well as recently completed phase three clinical studies and publication of a large number of allergen immunotherapy studies and metaanalyses have been the highlights of the last year.
Literature
1.
Bousquet J, Grattan C, Bieber T, Matricardi P, Simon HU, Wahn U, et al. Prediction and prevention of allergy and asthma in EAACI journals (2016). Clin Transl Allergy. 2017;7:46.PubMedPubMedCentralCrossRef
2.
Wahn U, Matricardi PM, Bieber T, Bousquet J, Grattan C, Simon HU, et al. Food allergy in EAACI journals (2016). Pediatr Allergy Immunol. 2017;28(8):825–30.PubMedCrossRef
3.
Ahmadizar F, Vijverberg SJH, Arets HGM, de Boer A, Garssen J, Kraneveld AD, et al. Breastfeeding is associated with a decreased risk of childhood asthma exacerbations later in life. Pediatr Allergy Immunol. 2017;28(7):649–54.PubMedCrossRef
4.
Zhang GQ, Liu B, Li J, Luo CQ, Zhang Q, Chen JL, et al. Fish intake during pregnancy or infancy and allergic outcomes in children: a systematic review and meta-analysis. Pediatr Allergy Immunol. 2017;28(2):152–61.PubMedCrossRef
5.
Tan JW, Turner PJ, Valerio C, Sertori R, Barnes EH, Campbell DE. Striking the balance between primary prevention of allergic disease and optimal infant growth and nutrition. Pediatr Allergy Immunol. 2017;28(8):844–7.PubMedCrossRef
6.
Alduraywish SA, Standl M, Lodge CJ, Abramson MJ, Allen KJ, Erbas B, et al. Is there a march from early food sensitization to later childhood allergic airway disease? Results from two prospective birth cohort studies. Pediatr Allergy Immunol. 2017;28(1):30–7.PubMedCrossRef
7.
Lule SA, Mpairwe H, Nampijja M, Akello F, Kabagenyi J, Namara B, et al. Life-course of atopy and allergy-related disease events in tropical sub-Saharan Africa: a birth cohort study. Pediatr Allergy Immunol. 2017;28(4):377–83.PubMedPubMedCentralCrossRef
8.
Ketelaar ME, van de Kant KD, Dijk FN, Klaassen EM, Grotenboer NS, Nawijn MC, et al. Predictive value of serum sST2 in preschool wheezers for development of asthma with high FeNO. Allergy. 2017;72(11):1811–5.PubMedCrossRef
9.
Christiansen ES, Kjaer HF, Eller E, Bindslev-Jensen C, Host A, Mortz CG, et al. Early childhood risk factors for rhinoconjunctivitis in adolescence: a prospective birth cohort study. Clin Transl Allergy. 2017;7:9.PubMedPubMedCentralCrossRef
10.
Lowe AJ, Angelica B, Su J, Lodge CJ, Hill DJ, Erbas B, et al. Age at onset and persistence of eczema are related to subsequent risk of asthma and hay fever from birth to 18 years of age. Pediatr Allergy Immunol. 2017;28(4):384–90.PubMedCrossRef
11.
Cavaleiro Rufo J, Madureira J, Paciencia I, Aguiar L, Pereira C, Silva D, et al. Indoor fungal diversity in primary schools may differently influence allergic sensitization and asthma in children. Pediatr Allergy Immunol. 2017;28(4):332–9.PubMedCrossRef
12.
Lundelin K, Poussa T, Salminen S, Isolauri E. Long-term safety and efficacy of perinatal probiotic intervention: evidence from a follow-up study of four randomized, double-blind, placebo-controlled trials. Pediatr Allergy Immunol. 2017;28(2):170–5.PubMedCrossRef
13.
Namara B, Nash S, Lule SA, Akurut H, Mpairwe H, Akello F, et al. Effects of treating helminths during pregnancy and early childhood on risk of allergy-related outcomes: follow-up of a randomized controlled trial. Pediatr Allergy Immunol. 2017;28(8):784–92.PubMedPubMedCentralCrossRef
14.
Toppila-Salmi S, Luukkainen A, Lemmetyinen R, Karjalainen J, Huhtala H, Renkonen R, et al. Birth decade affects the sensitization pattern and asthma risk in Finnish adult population. Allergy. 2017;72(11):1791–5.PubMedCrossRef
15.
Genuneit J, Seibold AM, Apfelbacher CJ, Konstantinou GN, Koplin JJ, La Grutta S, et al. The state of asthma epidemiology: an overview of systematic reviews and their quality. Clin Transl Allergy. 2017;7:12.PubMedPubMedCentralCrossRef
16.
Genuneit J, Seibold AM, Apfelbacher CJ, Konstantinou GN, Koplin JJ, La Grutta S, et al. Overview of systematic reviews in allergy epidemiology. Allergy. 2017;72(6):849–56.PubMedCrossRef
17.
Cingi C, Gevaert P, Mosges R, Rondon C, Hox V, Rudenko M, et al. Multi-morbidities of allergic rhinitis in adults: European Academy of Allergy and Clinical Immunology Task Force Report. Clin Transl Allergy. 2017;7:17.PubMedPubMedCentralCrossRef
18.
Chen Y, Wang H, Wong GWK, Zhong N, Li J. Allergen sensitization affected the change trend of prevalence of symptoms of rhinitis coexisting with wheeze among adolescents in Guangzhou City from 1994 to 2009. Pediatr Allergy Immunol. 2017;28(4):340–7.PubMedCrossRef
19.
Sorensen M, Klingenberg C, Wickman M, Sollid JUE, Furberg AS, Bachert C, et al. Staphylococcus aureus enterotoxin sensitization is associated with allergic poly-sensitization and allergic multimorbidity in adolescents. Allergy. 2017;72(10):1548–55.PubMedCrossRef
20.
Frohlich M, Pinart M, Keller T, Reich A, Cabieses B, Hohmann C, et al. Is there a sex-shift in prevalence of allergic rhinitis and comorbid asthma from childhood to adulthood? A meta-analysis. Clin Transl Allergy. 2017;7:44.PubMedPubMedCentralCrossRef
21.
Garcia-Larsen V, Arthur R, Potts JF, Howarth PH, Ahlstrom M, Haahtela T, et al. Is fruit and vegetable intake associated with asthma or chronic rhino-sinusitis in European adults? Results from the Global Allergy and Asthma Network of Excellence (GA(2)LEN) Survey. Clin Transl Allergy. 2017;7:3.PubMedPubMedCentralCrossRef
22.
Bousquet J, Onorato GL, Bachert C, Barbolini M, Bedbrook A, Bjermer L, et al. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report. Clin Transl Allergy. 2017;7:37.PubMedPubMedCentralCrossRef
23.
Alessandri C, Ferrara R, Bernardi ML, Zennaro D, Tuppo L, Giangrieco I, et al. Diagnosing allergic sensitizations in the third millennium: why clinicians should know allergen molecule structures. Clin Transl Allergy. 2017;7:21.PubMedPubMedCentralCrossRef
24.
Onell A, Whiteman A, Nordlund B, Baldracchini F, Mazzoleni G, Hedlin G, et al. Allergy testing in children with persistent asthma: comparison of four diagnostic methods. Allergy. 2017;72(4):590–7.PubMedCrossRef
25.
Chauveau A, Dalphin ML, Mauny F, Kaulek V, Schmausser-Hechfellner E, Renz H, et al. Skin prick tests and specific IgE in 10-year-old children: agreement and association with allergic diseases. Allergy. 2017;72(9):1365–73.PubMedCrossRef
26.
Pfaar O, Calderon MA, Andrews CP, Angjeli E, Bergmann KC, Bonlokke JH, et al. Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future—an EAACI Position Paper. Allergy. 2017;72(7):1035–42.PubMedCrossRef
27.
Boelke G, Berger U, Bergmann KC, Bindslev-Jensen C, Bousquet J, Gildemeister J, et al. Peak nasal inspiratory flow as outcome for provocation studies in allergen exposure chambers: a GA(2)LEN study. Clin Transl Allergy. 2017;7:33.PubMedPubMedCentralCrossRef
28.
Fux M, von Garnier C. Sputum basophils and asthma diagnosis: dawn of a new era? Allergy. 2017;72(10):1437–9.PubMedCrossRef
29.
Suzuki Y, Wakahara K, Nishio T, Ito S, Hasegawa Y. Airway basophils are increased and activated in eosinophilic asthma. Allergy. 2017;72(10):1532–9.PubMedCrossRef
30.
Brooks CR, van Dalen CJ, Hermans IF, Gibson PG, Simpson JL, Douwes J. Sputum basophils are increased in eosinophilic asthma compared with non-eosinophilic asthma phenotypes. Allergy. 2017;72(10):1583–6.PubMedCrossRef
31.
Portelli MA, Moseley C, Stewart CE, Postma DS, Howarth P, Warner JA, et al. Airway and peripheral urokinase plasminogen activator receptor is elevated in asthma, and identifies a severe, nonatopic subset of patients. Allergy. 2017;72(3):473–82.PubMedCrossRef
32.
Gangwar RS, Minai-Fleminger Y, Seaf M, Gutgold A, Shikotra A, Barber C, et al. CD48 on blood leukocytes and in serum of asthma patients varies with severity. Allergy. 2017;72(6):888–95.PubMedCrossRef
33.
James A, Janson C, Malinovschi A, Holweg C, Alving K, Ono J, et al. Serum periostin relates to type-2 inflammation and lung function in asthma: data from the large population-based cohort Swedish GA(2)LEN. Allergy. 2017;72(11):1753–60.PubMedCrossRef
34.
Milger K, Gotschke J, Krause L, Nathan P, Alessandrini F, Tufman A, et al. Identification of a plasma miRNA biomarker signature for allergic asthma: a translational approach. Allergy. 2017;72(12):1962–71.PubMedCrossRef
35.
36.
Chawes BL, Stokholm J, Schoos AM, Fink NR, Brix S, Bisgaard H. Allergic sensitization at school age is a systemic low-grade inflammatory disorder. Allergy. 2017;72(7):1073–80.PubMedCrossRef
37.
Birzele LT, Depner M, Ege MJ, Engel M, Kublik S, Bernau C, et al. Environmental and mucosal microbiota and their role in childhood asthma. Allergy. 2017;72(1):109–19.PubMedCrossRef
38.
Schroder PC, Illi S, Casaca VI, Lluis A, Bock A, Roduit C, et al. A switch in regulatory T cells through farm exposure during immune maturation in childhood. Allergy. 2017;72(4):604–15.PubMedCrossRef
39.
Nieuwenhuis MA, Vonk JM, Himes BE, Sarnowski C, Minelli C, Jarvis D, et al. PTTG1IP and MAML3, novel genomewide association study genes for severity of hyperresponsiveness in adult asthma. Allergy. 2017;72(5):792–801.PubMedCrossRef
40.
Loffredo LF, Abdala-Valencia H, Anekalla KR, Cuervo-Pardo L, Gottardi CJ, Berdnikovs S. Beyond epithelial-to-mesenchymal transition: common suppression of differentiation programs underlies epithelial barrier dysfunction in mild, moderate, and severe asthma. Allergy. 2017;72(12):1988–2004.PubMedCrossRef
41.
Rodriguez-Perez N, Schiavi E, Frei R, Ferstl R, Wawrzyniak P, Smolinska S, et al. Altered fatty acid metabolism and reduced stearoyl-coenzyme a desaturase activity in asthma. Allergy. 2017;72(11):1744–52.PubMedCrossRef
42.
Chachi L, Abbasian M, Gavrila A, Alzahrani A, Tliba O, Bradding P, et al. Protein phosphatase 5 mediates corticosteroid insensitivity in airway smooth muscle in patients with severe asthma. Allergy. 2017;72(1):126–36.PubMedCrossRef
43.
Rodrigo GJ, Neffen H. Efficacy and safety of tiotropium in school-age children with moderate-to-severe symptomatic asthma: a systematic review. Pediatr Allergy Immunol. 2017;28(6):573–8.PubMedCrossRef
44.
Wartna JB, Bohnen AM, Elshout G, Pijnenburg MW, Pols DH, Gerth van Wijk RR, et al. Symptomatic treatment of pollen-related allergic rhinoconjunctivitis in children: randomized controlled trial. Allergy. 2017;72(4):636–44.PubMedCrossRef
45.
De Greve G, Hellings PW, Fokkens WJ, Pugin B, Steelant B, Seys SF. Endotype-driven treatment in chronic upper airway diseases. Clin Transl Allergy. 2017;7:22.PubMedPubMedCentralCrossRef
46.
Hellings PW, Fokkens WJ, Bachert C, Akdis CA, Bieber T, Agache I, et al. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis—A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017;72(9):1297–305.CrossRefPubMed
47.
Brandstetter S, Finger T, Fischer W, Brandl M, Bohmer M, Pfeifer M, et al. Differences in medication adherence are associated with beliefs about medicines in asthma and COPD. Clin Transl Allergy. 2017;7:39.PubMedPubMedCentralCrossRef
48.
Pollard S, Bansback N, FitzGerld JM, Bryan S. The burden of nonadherence among adults with asthma: a role for shared decision-making. Allergy. 2017;72(5):705–12.PubMedCrossRef
49.
Drummond D, Monnier D, Tesniere A, Hadchouel A. A systematic review of serious games in asthma education. Pediatr Allergy Immunol. 2017;28(3):257–65.PubMedCrossRef
50.
Everhart RS, Heron KE, Leibach GG, Miadich SA. Developing a mobile health intervention for low-income, urban caregivers of children with asthma: a pilot study. Pediatr Allergy Immunol Pulmonol. 2017;30(4):252–6.PubMedCrossRefPubMedCentral
51.
Trischler J, Lieb A, Arnold M, Schulze J, Rosewich M, Schubert R, et al. Omalizumab effectively protects against early and late allergic responses in asthma after 4 weeks. Allergy. 2017;72(12):1912–5.PubMedCrossRef
52.
Paganin F, Mangiapan G, Proust A, Prudhomme A, Attia J, Marchand-Adam S, et al. Lung function parameters in omalizumab responder patients: an interesting tool? Allergy. 2017;72(12):1953–61.PubMedCrossRef
53.
Riccio AM, Mauri P, De Ferrari L, Rossi R, Di Silvestre D, Benazzi L, et al. Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months. Clin Transl Allergy. 2017;7:6.PubMedPubMedCentralCrossRef
54.
Bersuch E, Graf F, Renner ED, Jung A, Traidl-Hoffmann C, Lauener R, et al. Lung function improvement and airways inflammation reduction in asthmatic children after a rehabilitation program at moderate altitude. Pediatr Allergy Immunol. 2017;28(8):768–75.PubMedCrossRef
55.
Netts P, Michaelis LJ. An interpretation of the new international MAP guideline for the management of Milk Allergy in Primary Care. Clin Transl Allergy. 2017;7:34.PubMedPubMedCentralCrossRef
56.
Sheikh A, Sheikh Z, Roberts G, Muraro A, Dhami S, Sheikh A. National clinical practice guidelines for food allergy and anaphylaxis: an international assessment. Clin Transl Allergy. 2017;7:23.PubMedPubMedCentralCrossRef
57.
Asamoah F, Kakourou A, Dhami S, Lau S, Agache I, Muraro A, et al. Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews. Clin Transl Allergy. 2017;7:25.PubMedPubMedCentralCrossRef
58.
Dhami S, Kakourou A, Asamoah F, Agache I, Lau S, Jutel M, et al. Allergen immunotherapy for allergic asthma: a systematic review and meta-analysis. Allergy. 2017;72(12):1825–48.PubMedCrossRef
59.
Dhami S, Nurmatov U, Arasi S, Khan T, Asaria M, Zaman H, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis. Allergy. 2017;72(11):1597–631.PubMedCrossRef
60.
Nurmatov U, Dhami S, Arasi S, Roberts G, Pfaar O, Muraro A, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews. Clin Transl Allergy. 2017;7:24.PubMedPubMedCentralCrossRef
61.
Kristiansen M, Dhami S, Netuveli G, Halken S, Muraro A, Roberts G, et al. Allergen immunotherapy for the prevention of allergy: a systematic review and meta-analysis. Pediatr Allergy Immunol. 2017;28(1):18–29.PubMedCrossRef
62.
Nurmatov U, Dhami S, Arasi S, Pajno GB, Fernandez-Rivas M, Muraro A, et al. Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis. Allergy. 2017;72(8):1133–47.PubMedCrossRef
63.
Halken S, Larenas-Linnemann D, Roberts G, Calderon MA, Angier E, Pfaar O, et al. EAACI guidelines on allergen immunotherapy: prevention of allergy. Pediatr Allergy Immunol. 2017;28(8):728–45.PubMedCrossRef
64.
Di Bona D, Plaia A, Leto-Barone MS, La Piana S, Macchia L, Di Lorenzo G. Efficacy of allergen immunotherapy in reducing the likelihood of developing new allergen sensitizations: a systematic review. Allergy. 2017;72(5):691–704.PubMedCrossRef
65.
Matsuoka T, Bernstein DI, Masuyama K, Nolte H, Okamiya K, Seitzberg D, et al. Pooled efficacy and safety data for house dust mite sublingual immunotherapy tablets in adolescents. Pediatr Allergy Immunol. 2017;28(7):661–7.PubMedCrossRef
66.
Demoly P, Kleine-Tebbe J, Rehm D. Clinical benefits of treatment with SQ house dust mite sublingual tablet in house dust mite allergic rhinitis. Allergy. 2017;72(10):1576–8.PubMedCrossRef
67.
Okamoto Y, Fujieda S, Okano M, Yoshida Y, Kakudo S, Masuyama K. House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis. Allergy. 2017;72(3):435–43.PubMedCrossRef
68.
Huser C, Dieterich P, Singh J, Shah-Hosseini K, Allekotte S, Lehmacher W, et al. A 12-week DBPC dose-finding study with sublingual monomeric allergoid tablets in house dust mite-allergic patients. Allergy. 2017;72(1):77–84.PubMedCrossRef
69.
Treudler R, Franke A, Schmiedeknecht A, Ballmer-Weber B, Worm M, Werfel T, et al. BASALIT trial: double-blind placebo-controlled allergen immunotherapy with rBet v 1-FV in birch-related soya allergy. Allergy. 2017;72(8):1243–53.PubMedCrossRef
70.
Bozek A, Kolodziejczyk K, Kozlowska R, Canonica GW. Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial. Clin Transl Allergy. 2017;7:43.PubMedPubMedCentralCrossRef
71.
Calderon MA, Vidal C, Rodriguez Del Rio P, Just J, Pfaar O, Tabar AI, et al. European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment. Allergy. 2017;72(3):462–72.PubMedCrossRef
72.
Rodriguez Del Rio P, Vidal C, Just J, Tabar AI, Sanchez-Machin I, Eberle P, et al. The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a paediatric assessment. Pediatr Allergy Immunol. 2017;28(1):60–70.PubMedCrossRef
73.
Tavakoli H, FitzGerald JM, Chen W, Lynd L, Kendzerska T, Aaron S, et al. Ten-year trends in direct costs of asthma: a population-based study. Allergy. 2017;72(2):291–9.PubMedCrossRef
74.
Colas C, Brosa M, Anton E, Montoro J, Navarro A, Dordal MT, et al. Estimate of the total costs of allergic rhinitis in specialized care based on real-world data: the FERIN Study. Allergy. 2017;72(6):959–66.PubMedCrossRef
75.
Bousquet J, Bewick M, Arnavielhe S, Mathieu-Dupas E, Murray R, Bedbrook A, et al. Work productivity in rhinitis using cell phones: the MASK pilot study. Allergy. 2017;72(10):1475–84.CrossRefPubMed
76.
Belhassen M, Demoly P, Bloch-Morot E, de Pouvourville G, Ginoux M, Chartier A, et al. Costs of perennial allergic rhinitis and allergic asthma increase with severity and poor disease control. Allergy. 2017;72(6):948–58.PubMedCrossRef
77.
Ferreira de Magalhaes M, Amaral R, Pereira AM, Sa-Sousa A, Azevedo I, Azevedo LF, et al. Cost of asthma in children: a nationwide, population-based, cost-of-illness study. Pediatr Allergy Immunol. 2017;28(7):683–91.PubMedCrossRef
78.
Hellings PW, Borrelli D, Pietikainen S, Agache I, Akdis C, Bachert C, et al. European summit on the prevention and self-management of chronic respiratory diseases: report of the European Union Parliament Summit (29 March 2017). Clin Transl Allergy. 2017;7:49.PubMedPubMedCentralCrossRef
79.
Muraro A, Steelant B, Pietikainen S, Borrelli D, Childers N, Callebaut I, et al. European symposium on the awareness of allergy: report of the promotional campaign in the European Parliament (26–28 April 2016). Allergy. 2017;72(2):173–6.PubMedCrossRef
80.
Del Giacco SR, Bakirtas A, Bel E, Custovic A, Diamant Z, Hamelmann E, et al. Allergy in severe asthma. Allergy. 2017;72(2):207–20.PubMedCrossRef
81.
Pfaar O, Bastl K, Berger U, Buters J, Calderon MA, Clot B, et al. Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis—an EAACI position paper. Allergy. 2017;72(5):713–22.PubMedCrossRef
82.
Jensen-Jarolim E, Bax HJ, Bianchini R, Capron M, Corrigan C, Castells M, et al. AllergoOncology—the impact of allergy in oncology: EAACI position paper. Allergy. 2017;72(6):866–87.PubMedCrossRef
83.
Shamji MH, Kappen JH, Akdis M, Jensen-Jarolim E, Knol EF, Kleine-Tebbe J, et al. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper. Allergy. 2017;72(8):1156–73.PubMedCrossRef
84.
Leonardi A, Doan S, Fauquert JL, Bozkurt B, Allegri P, Marmouz F, et al. Diagnostic tools in ocular allergy. Allergy. 2017;72(10):1485–98.PubMedCrossRef
85.
Hellings PW, Klimek L, Cingi C, Agache I, Akdis C, Bachert C, et al. Non-allergic rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2017;72(11):1657–65.PubMedCrossRef
Metadata
Title
Highlights and recent developments in airway diseases in EAACI journals (2017)
Authors
J. Bousquet
C. A. Akdis
C. Grattan
P. A. Eigenmann
K. Hoffmann-Sommergruber
P. W. Hellings
I. Agache
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Clinical and Translational Allergy / Issue 1/2018
Electronic ISSN: 2045-7022
DOI
https://doi.org/10.1186/s13601-018-0238-3

Other articles of this Issue 1/2018

Clinical and Translational Allergy 1/2018 Go to the issue

Review

An EAACI task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity

Review

Epidemiology of spider mite sensitivity: a meta-analysis and systematic review

Research

Cross-sectional study on sensitization to mite and cockroach allergen components in allergy patients in the Central European region

Research

Maternal exposure to farming environment protects offspring against allergic diseases by modulating the neonatal TLR-Tregs-Th axis

Letter to the Editor

Normocomplementaemic urticarial vasculitis: effective treatment with omalizumab

Brief communication

MI (2-methyl-4-isothiazolin-3-one) contained in detergents is not detectable in machine washed textiles